A Study of the Metabolic Reconstruction Oral Biologics (Gut-X-001) Medication in People With Alzheimer's Disease (ESCAPE-AD)
Clinical trial NCT07591727 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07591727
- Sponsor
- Beijing Tiantan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.